152 related articles for article (PubMed ID: 34419565)
1. Coronary Artery Calcifications and Cardiac Risk After Radiation Therapy for Stage III Lung Cancer.
Wang K; Malkin HE; Patchett ND; Pearlstein KA; Heiling HM; McCabe SD; Deal AM; Mavroidis P; Oakey M; Fenoli J; Lee CB; Klein JL; Jensen BC; Stinchcombe TE; Marks LB; Weiner AA
Int J Radiat Oncol Biol Phys; 2022 Jan; 112(1):188-196. PubMed ID: 34419565
[TBL] [Abstract][Full Text] [Related]
2. Cardiac Toxicity After Radiotherapy for Stage III Non-Small-Cell Lung Cancer: Pooled Analysis of Dose-Escalation Trials Delivering 70 to 90 Gy.
Wang K; Eblan MJ; Deal AM; Lipner M; Zagar TM; Wang Y; Mavroidis P; Lee CB; Jensen BC; Rosenman JG; Socinski MA; Stinchcombe TE; Marks LB
J Clin Oncol; 2017 May; 35(13):1387-1394. PubMed ID: 28113017
[TBL] [Abstract][Full Text] [Related]
3. Mean Heart Dose Is an Inadequate Surrogate for Left Anterior Descending Coronary Artery Dose and the Risk of Major Adverse Cardiac Events in Lung Cancer Radiation Therapy.
Atkins KM; Bitterman DS; Chaunzwa TL; Kozono DE; Baldini EH; Aerts HJWL; Tamarappoo BK; Hoffmann U; Nohria A; Mak RH
Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1473-1479. PubMed ID: 33713743
[TBL] [Abstract][Full Text] [Related]
4. Heart dosimetric analysis of three types of cardiac toxicity in patients treated on dose-escalation trials for Stage III non-small-cell lung cancer.
Wang K; Pearlstein KA; Patchett ND; Deal AM; Mavroidis P; Jensen BC; Lipner MB; Zagar TM; Wang Y; Lee CB; Eblan MJ; Rosenman JG; Socinski MA; Stinchcombe TE; Marks LB
Radiother Oncol; 2017 Nov; 125(2):293-300. PubMed ID: 29050957
[TBL] [Abstract][Full Text] [Related]
5. Association of Left Anterior Descending Coronary Artery Radiation Dose With Major Adverse Cardiac Events and Mortality in Patients With Non-Small Cell Lung Cancer.
Atkins KM; Chaunzwa TL; Lamba N; Bitterman DS; Rawal B; Bredfeldt J; Williams CL; Kozono DE; Baldini EH; Nohria A; Hoffmann U; Aerts HJWL; Mak RH
JAMA Oncol; 2021 Feb; 7(2):206-219. PubMed ID: 33331883
[TBL] [Abstract][Full Text] [Related]
6. Cardiac Events After Radiation Therapy: Combined Analysis of Prospective Multicenter Trials for Locally Advanced Non-Small-Cell Lung Cancer.
Dess RT; Sun Y; Matuszak MM; Sun G; Soni PD; Bazzi L; Murthy VL; Hearn JWD; Kong FM; Kalemkerian GP; Hayman JA; Ten Haken RK; Lawrence TS; Schipper MJ; Jolly S
J Clin Oncol; 2017 May; 35(13):1395-1402. PubMed ID: 28301264
[TBL] [Abstract][Full Text] [Related]
7. Cardiac Radiation Dose, Cardiac Disease, and Mortality in Patients With Lung Cancer.
Atkins KM; Rawal B; Chaunzwa TL; Lamba N; Bitterman DS; Williams CL; Kozono DE; Baldini EH; Chen AB; Nguyen PL; D'Amico AV; Nohria A; Hoffmann U; Aerts HJWL; Mak RH
J Am Coll Cardiol; 2019 Jun; 73(23):2976-2987. PubMed ID: 31196455
[TBL] [Abstract][Full Text] [Related]
8. Dosimetric Predictors of Symptomatic Cardiac Events After Conventional-Dose Chemoradiation Therapy for Inoperable NSCLC.
Yegya-Raman N; Wang K; Kim S; Reyhan M; Deek MP; Sayan M; Li D; Patel M; Malhotra J; Aisner J; Marks LB; Jabbour SK
J Thorac Oncol; 2018 Oct; 13(10):1508-1518. PubMed ID: 29883836
[TBL] [Abstract][Full Text] [Related]
9. Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: the Duke experience.
Sibley GS; Jamieson TA; Marks LB; Anscher MS; Prosnitz LR
Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):149-54. PubMed ID: 9422571
[TBL] [Abstract][Full Text] [Related]
10. Cardiac Dose in Locally Advanced Lung Cancer: Results From a Statewide Consortium.
Dess RT; Sun Y; Muenz DG; Paximadis PA; Dominello MM; Grills IS; Kestin LL; Movsas B; Masi KJ; Matuszak MM; Radawski JD; Moran JM; Pierce LJ; Hayman JA; Schipper MJ; Jolly S;
Pract Radiat Oncol; 2020; 10(1):e27-e36. PubMed ID: 31382026
[TBL] [Abstract][Full Text] [Related]
11. Results of high-dose thoracic irradiation incorporating beam's eye view display in non-small cell lung cancer: a retrospective multivariate analysis.
Hazuka MB; Turrisi AT; Lutz ST; Martel MK; Ten Haken RK; Strawderman M; Borema PL; Lichter AS
Int J Radiat Oncol Biol Phys; 1993 Sep; 27(2):273-84. PubMed ID: 8407401
[TBL] [Abstract][Full Text] [Related]
12. Assessment of lung cancer response after nonoperative therapy: tumor diameter, bidimensional product, and volume. A serial CT scan-based study.
Werner-Wasik M; Xiao Y; Pequignot E; Curran WJ; Hauck W
Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):56-61. PubMed ID: 11516851
[TBL] [Abstract][Full Text] [Related]
13. The Association of Incidental Radiation Dose to the Heart Base with Overall Survival and Cardiac Events after Curative-intent Radiotherapy for Non-small Cell Lung Cancer: Results from the NI-HEART Study.
Walls GM; O'Connor J; Harbinson M; Duane F; McCann C; McKavanagh P; Johnston DI; Giacometti V; McAleese J; Hounsell AR; Cole AJ; Butterworth KT; McGarry CK; Hanna GG; Jain S
Clin Oncol (R Coll Radiol); 2024 Feb; 36(2):119-127. PubMed ID: 38042669
[TBL] [Abstract][Full Text] [Related]
14. Dosimetric Predictors of Cardiotoxicity in Thoracic Radiotherapy for Lung Cancer.
Borkenhagen JF; Bergom C; Rapp CT; Klawikowski SJ; Rein LE; Gore EM
Clin Lung Cancer; 2019 Nov; 20(6):435-441. PubMed ID: 31303452
[TBL] [Abstract][Full Text] [Related]
15. Left Anterior Descending Coronary Artery Radiation Dose Association With All-Cause Mortality in NRG Oncology Trial RTOG 0617.
McKenzie E; Zhang S; Zakariaee R; Guthier CV; Hakimian B; Mirhadi A; Kamrava M; Padda SK; Lewis JH; Nikolova A; Mak RH; Atkins KM
Int J Radiat Oncol Biol Phys; 2023 Apr; 115(5):1138-1143. PubMed ID: 36436615
[TBL] [Abstract][Full Text] [Related]
16. Major adverse cardiac event risk prediction model incorporating baseline Cardiac disease, Hypertension, and Logarithmic Left anterior descending coronary artery radiation dose in lung cancer (CHyLL).
Tjong MC; Bitterman DS; Brantley K; Nohria A; Hoffmann U; Atkins KM; Mak RH
Radiother Oncol; 2022 Apr; 169():105-113. PubMed ID: 35182687
[TBL] [Abstract][Full Text] [Related]
17. The treatment of stage III nonsmall cell lung cancer using high dose conformal radiotherapy.
Sibley GS; Mundt AJ; Shapiro C; Jacobs R; Chen G; Weichselbaum R; Vijayakumar S
Int J Radiat Oncol Biol Phys; 1995 Dec; 33(5):1001-7. PubMed ID: 7493826
[TBL] [Abstract][Full Text] [Related]
18. A clinical study of shrinking field radiation therapy based on (18)F-FDG PET/CT for stage III non-small cell lung cancer.
Ding X; Li H; Wang Z; Huang W; Li B; Zang R; Sun H; Yi Y
Technol Cancer Res Treat; 2013 Jun; 12(3):251-7. PubMed ID: 23289475
[TBL] [Abstract][Full Text] [Related]
19. Cardiac Dose and Survival After Stereotactic Body Radiotherapy for Early-stage Non-Small-cell Lung Cancer.
Tembhekar AR; Wright CL; Daly ME
Clin Lung Cancer; 2017 May; 18(3):293-298. PubMed ID: 28089158
[TBL] [Abstract][Full Text] [Related]
20. Increased therapeutic ratio by 18FDG-PET CT planning in patients with clinical CT stage N2-N3M0 non-small-cell lung cancer: a modeling study.
van Der Wel A; Nijsten S; Hochstenbag M; Lamers R; Boersma L; Wanders R; Lutgens L; Zimny M; Bentzen SM; Wouters B; Lambin P; De Ruysscher D
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):649-55. PubMed ID: 15708242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
